Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3917-3933
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3917
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3917
Figure 1 Overview of study design.
HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; miRNA: Micro ribonucleic acid; NGS: Next-generation sequencing; RT-qPCR: Real-time quantitative PCR.
- Citation: Malik J, Klammer M, Rolny V, Chan HLY, Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, Swiatek-de Lange M. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2022; 28(29): 3917-3933
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3917